tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
David Bailey

David Bailey

Macquarie
Wall Street Analyst
Ranked #5,914 out of 8,050 Analysts on TipRanks (#15,845 out of 21,576 overall experts)

Success Rate

20%
1 out of 5 Profitable Transactions

Average Return

-5.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied David Bailey's ratings since 2021 and opened each position for the duration of 1 Year:
20.00% of your transactions would have been profitable with an average return of -5.1%

Stock Rating Distribution

11Ratings
54.55% Buy
36.36% Hold
9.09% Sell
Distribution of David Bailey's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Ansell Limited
(ANSLF)
Rating Type:Buy
Dates:Jul 17, 2022 - Jan 01, 1970
Gain:11.00%
The most profitable rating made by David Bailey

David Bailey's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Mayne Pharma Group Limited
Jan 21, 2021
Hold
Reiterated
$0.25
(-13.85% Downside)
0.00%
1
Polynovo Limited
Jan 21, 2021
Hold
Downgraded
$1.93
(37.87% Upside)
0.00%
1
Mar 11, 2021
Hold
Reiterated
$202.15
(0.32% Upside)
0.00%
1
Sonic Healthcare
Aug 24, 2021
Hold
Reiterated
0.00%
1
Resmed
Dec 06, 2021
Buy
Upgraded
0%
-13.45%
2
PHCRF
Healius Limited
Mar 15, 2022
Buy
Reiterated
0.00%
1
Ramsay Health Care
May 05, 2022
Buy
Reiterated
$61.77
(28.75% Upside)
0%
-4.90%
3
Ansell
Jul 17, 2022
Buy
Upgraded
$19.55
(11.96% Upside)
100%
+11.00%
1
List of latest recommendations made by David Bailey. Click to expand and see David Bailey's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More